NCT03080298 - Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire | Biotech Hunter

Enrollment

119

Participants

Timeline

Start Date

March 14, 2016

Primary Completion Date

April 4, 2017

Study Completion Date

July 25, 2017

Conditions

Hypoactive Sexual Desire Disorder (HSDD)

Interventions

DRUG

BP101

DRUG

Placebo

Trial Locations (12)

V.M. Bekhterev Republic Clinical Psychiatric Hospital, Kazan'

"People's Friendship University of Russia", Moscow

Mental Health Research Center, Moscow

N.A. Alexeev Moscow Psychiatric Clinical Hospital #1, Moscow

Clinical Psychiatry Hospital №1, Nizhny Novgorod

Orenburg Regional Clinical Psychiatric Hospital #1, Orenburg

OrKli Hospital LLC, Saint Petersburg

Regional Clinical Psychiatric Hospital of St. Sofia, Saratov

Engels Psycyatric hospital, Saratov Oblast

"Clinic Hundred Years", Tomsk

Yaroslavl Regional Clinical Psychiatric Hospital, Yaroslavl

Sverdlovsk Regional Clinical Psychiatric Hospital, Yekaterinburg

All Listed Sponsors

lead

Ivix LLX

INDUSTRY